Literature DB >> 15929172

Correlative studies on bFGF mRNA and MMP-9 mRNA expressions with microvascular density, progression, and prognosis of gastric carcinomas.

Zhong-Sheng Zhao1, Ji-Lin Zhou, Gen-You Yao, Guo-Qing Ru, Jie Ma, Jun Ruan.   

Abstract

AIM: To investigate the mRNA expressions of bFGF and MMP-9 in gastric carcinomas so as to reveal their correlations with tumor microvascular density (MVD), invasion, metastasis, and prognosis.
METHODS: In situ hybridization and immunohistochemical techniques were used to detect the expressions of bFGFmRNA and MMP-9mRNA and the proteins of CD34 in 105 specimens of gastric carcinomas.
RESULTS: In situ hybridization study showed that positive rates of bFGF mRNA and MMP-9mRNA expressions were 60.95% and 59.19%; the mean MVD was 46.09+/-11.52 and 43.75+/-13.41, respectively in piece/0.72 mm(2) in tumors with bFGFmRNA and MMP-9mRNA positive expressions, which were significantly higher than those with negative expression (29.41+/-12.47; 33.45+/-13.92 piece/0.72 mm(2), respectively). The positive expression rates of bFGFmRNA and MMP-9mRNA were correlated to the tumor invasion depth (r(s) = 0.211, P = 0.031; r(s) = 0.335, P = 0.001), growing pattern (r(s) = 0.324, P = 0.001; r(s) = 0.267, P = 0.006), vessel invasion (r(s) = 0.579, P = 0.001; r(s) = 0.209, P = 0.032), lymph node metastasis (r(s) = 0.405, P = 0.001; r(s) = 0.343, P = 0.001) and distant metastasis (r(s) = 0.474, P = 0.001; r(s) = 0.468, P = 0.001), but not correlated to tumor type (r(s) = 0.134, P = 0.173; r(s) = 0.103, P = 0.145) and differentiations (r(s) = 0.096, P = 0.332; r(s) = 0.102, P = 0.298). The mean MVD was much higher in the tumors with infiltrating growth at stage T(3)-T(4), with vessel invasion, lymph node metastasis and distant metastasis than those with expanding growth type (t = 10.105, P = 0.001) at stage T(1)-T(2) (t = 5.961, P = 0.001), with non-vessel invasion (t = 7.394, P = 0.001), non-lymph node metastasis (t = 3.819, P = 0.01) and non-distant metastasis (t = 10.578, P = 0.001). Positive correlation was observed between MVD and the expressions of bFGFmRNA and MMP-9mRNA (t = 3.207, P = 0.002; t = 7.035, P = 0.001, respectively). The mean survival time and 5-year survival rate were lower in cases with MVD over 39.5 and the positive expressions of bFGFmRNA and MMP-9mRNA than those with MVD less than 39.5 and the negative expressions of bFGFmRNA and MMP-9mRNA.
CONCLUSION: bFGF and MMP-9 promote the angiogenesis of the gastric cancers. Detection of the expressions of bFGF and MMP-9 can serve as a useful index to determine the angiogenesis, invasion, metastasis, and prognosis of gastric cancers.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15929172      PMCID: PMC4316053          DOI: 10.3748/wjg.v11.i21.3227

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  30 in total

1.  The clinicopathological significance of heparanase and basic fibroblast growth factor expressions in hepatocellular carcinoma.

Authors:  O N El-Assal; A Yamanoi; T Ono; H Kohno; N Nagasue
Journal:  Clin Cancer Res       Date:  2001-05       Impact factor: 12.531

Review 2.  Angiogenesis and cancer metastasis.

Authors:  I J Fidler
Journal:  Cancer J       Date:  2000-04       Impact factor: 3.360

3.  Synergistic effect of basic fibroblast growth factor and vascular endothelial growth factor in murine hepatocellular carcinoma.

Authors:  Hitoshi Yoshiji; Shigeki Kuriyama; Junichi Yoshii; Yasuhide Ikenaka; Ryuichi Noguchi; Daniel J Hicklin; James Huber; Toshiya Nakatani; Hirohisa Tsujinoue; Koji Yanase; Hiroo Imazu; Hiroshi Fukui
Journal:  Hepatology       Date:  2002-04       Impact factor: 17.425

4.  The expression of basic fibroblast growth factor and vascular endothelial growth factor in prostatic adenocarcinoma: correlation with neovascularization.

Authors:  T Sugamoto; N Tanji; K Sato; H Fujita; S Nishio; M Sakanaka; M Yokoyama
Journal:  Anticancer Res       Date:  2001 Jan-Feb       Impact factor: 2.480

5.  Quantification of angiogenesis as a prognostic marker in human carcinomas: a critical evaluation of histopathological methods for estimation of vascular density.

Authors:  B V Offersen; M Borre; J Overgaard
Journal:  Eur J Cancer       Date:  2003-05       Impact factor: 9.162

6.  Histologic features of venous invasion, expression of vascular endothelial growth factor and matrix metalloproteinase-2 and matrix metalloproteinase-9, and the relation with liver metastasis in pancreatic cancer.

Authors:  Yuichi Nagakawa; Tatsuya Aoki; Kazuhiko Kasuya; Akihiko Tsuchida; Yasuhisa Koyanagi
Journal:  Pancreas       Date:  2002-03       Impact factor: 3.327

7.  Correlation of serum basic fibroblast growth factor levels with clinicopathologic features and postoperative recurrence in hepatocellular carcinoma.

Authors:  R T Poon; I O Ng; C Lau; W C Yu; S T Fan; J Wong
Journal:  Am J Surg       Date:  2001-09       Impact factor: 2.565

Review 8.  Angiogenesis: new insights and therapeutic potential.

Authors:  R J Tomanek; G C Schatteman
Journal:  Anat Rec       Date:  2000-06-15

9.  Angiogenesis extent and expression of matrix metalloproteinase-2 and -9 agree with progression of ovarian endometriomas.

Authors:  R Ria; G Loverro; A Vacca; D Ribatti; G Cormio; A M Roccaro; L Selvaggi
Journal:  Eur J Clin Invest       Date:  2002-03       Impact factor: 4.686

10.  Angiogenesis as determined by computerised image analysis and the risk of early relapse in women with invasive ductal breast carcinoma.

Authors:  Sławomir Olewniczak; Maria Chosia; Blanka Kołodziej; Artur Kwas; Andrzej Kram; Wenancjusz Domagała
Journal:  Pol J Pathol       Date:  2003       Impact factor: 1.072

View more
  9 in total

Review 1.  Role of receptor tyrosine kinases in gastric cancer: new targets for a selective therapy.

Authors:  J C Becker; C Muller-Tidow; H Serve; W Domschke; T Pohle
Journal:  World J Gastroenterol       Date:  2006-06-07       Impact factor: 5.742

2.  MicroRNA-195 inhibits human gastric cancer by directly targeting basic fibroblast growth factor.

Authors:  J Wang; L Li; M Jiang; Y Li
Journal:  Clin Transl Oncol       Date:  2017-05-12       Impact factor: 3.405

3.  IL-22 promotes the migration and invasion of gastric cancer cells via IL-22R1/AKT/MMP-9 signaling.

Authors:  Yinghua Ji; Xiaoyu Yang; Jinsong Li; Zhihong Lu; Xiaorui Li; Jian Yu; Na Li
Journal:  Int J Clin Exp Pathol       Date:  2014-06-15

4.  Low microvascular density at the tumor center is related to the expression of metalloproteases and their inhibitors and with the occurrence of distant metastasis in breast carcinomas.

Authors:  Oscar Fernández-Guinea; Almudena Álvarez-Cofiño; Noemí Eiró; Luis O González; José M del Casar; Belen Fernandez-Garcia; Maria L Lamelas; Alejandro Andicoechea; Francisco J Vizoso
Journal:  Int J Clin Oncol       Date:  2012-06-12       Impact factor: 3.402

5.  Chromatin-remodeling factors mediate the balance of sense-antisense transcription at the FGF2 locus.

Authors:  Lori A McEachern; Paul R Murphy
Journal:  Mol Endocrinol       Date:  2014-02-19

6.  Histone deacetylase inhibitors: the anticancer, antimetastatic and antiangiogenic activities of AN-7 are superior to those of the clinically tested AN-9 (Pivanex).

Authors:  Nataly Tarasenko; Abraham Nudelman; Igor Tarasenko; Michal Entin-Meer; Daphne Hass-Kogan; Aida Inbal; Ada Rephaeli
Journal:  Clin Exp Metastasis       Date:  2008-05-28       Impact factor: 5.150

Review 7.  Phage displayed peptides/antibodies recognizing growth factors and their tyrosine kinase receptors as tools for anti-cancer therapeutics.

Authors:  Roberto Ronca; Patrizia Benzoni; Angela De Luca; Elisabetta Crescini; Patrizia Dell'Era
Journal:  Int J Mol Sci       Date:  2012-04-24       Impact factor: 6.208

8.  Constitutive phosphorylation of the FOXO1 transcription factor in gastric cancer cells correlates with microvessel area and the expressions of angiogenesis-related molecules.

Authors:  Sue Youn Kim; Jiyeon Yoon; Young San Ko; Mee Soo Chang; Jong-Wan Park; Hee Eun Lee; Min A Kim; Ji Hun Kim; Woo Ho Kim; Byung Lan Lee
Journal:  BMC Cancer       Date:  2011-06-22       Impact factor: 4.430

9.  Expression of annexin A2 in adenomyosis and dysmenorrhea.

Authors:  Feng Liu; Lixue Liu; Jian Zheng
Journal:  Arch Gynecol Obstet       Date:  2019-06-10       Impact factor: 2.344

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.